Publications

Journal Article
Review
Ppublish 22 citations
Electronic publication date
February 10, 1999

View on Pubmed.gov 9951682 | View on doi.org 10.1007/BF02787...

Oligoclonal T cells in human cancer.

Search for publications in this journal Med Oncol - 15(4):203-11

  • E Halapi

    Search for this expert
    1

Abstract

Many solid tumors are characterised by the infiltration of lymphocytes and their presence has been correlated with a more favourable prognosis. These tumor-infiltrating lymphocytes (TIL), have been shown to possess specific cytolytic reactivity towards autologous tumours, thus suggesting that tumour cells may express antigens capable of eliciting an immune response. Expression of such tumour-associated antigens (TAA) in combination with appropriate accessory signals would lead to the in vivo accumulation of T cells with anti-tumour specificity. Analysis of the composition of the specific T-cell receptor (TCR) of TIL could thus provide information on the nature of the antigen(s) recognised by TIL. In this review, different aspects of the presence of clonal T cells in patients with cancer are discussed.

References

Blood. 1996 Apr 15;87(8):3297-306

Leukemia. 1997 Aug;11(8):1312-7

J Immunol. 1994 May 15;152(10):4993-9

Science. 1996 Jun 21;272(5269):1755-62

Cited by 22 citations (total)

Journal Article

Soluble Fas ligand released by colon adenocarcinoma cells induces host lymphocyte apoptosis: an active mode of immune evasion in colon cancer.

Electronic publication date January 5, 2002

Search for publications in this journal Br J Cancer

E Song [...] U Heemann et al.

Expression of membrane-bound Fas ligand (mFasL) on colon cancer cells serves as a potential mechanism to inhibit host immune function...

Journal Article Research Support, Non-U.S. Gov't

Silencing Fas-associated phosphatase 1 expression enhances efficiency of chemotherapy for colon carcinoma with oxaliplatin.

Electronic publication date March 2, 2010

Search for publications in this journal World J Gastroenterol

Zhi-Yu Xiao [...] He-Rui Yao et al.

AIM

To investigate whether silencing Fas-associated phosphatase 1 (FAP-1) expression enhances the efficiency of chemotherapy for colon carcinoma with oxaliplatin.

METHODS

Expression of...

Conflict of interest statement

No conflict of interest statement provided.

MeSH

Specialties

Substances